My research focuses on personalised acute medicine, with acute infections as the focus. The aim is early biological differentiation between viral and bacterial infections, including in immunocompromised patients, so that treatment can be started in time and targeted. I am also setting up research on better risk stratification for short- and long-term cardiovascular events after acute infection, combining clinical data with immunological, proteomic and transcriptomic profiles to identify biological subtypes and mechanisms of cardiovascular vulnerability, with the ultimate aim of personalised treatment and targeted prevention.
